Evaluation of Treosulfan Pharmacokinetics (PK) in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

Trial Profile

Evaluation of Treosulfan Pharmacokinetics (PK) in Children Undergoing Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Treosulfan (Primary)
  • Indications Transplant rejection
  • Focus Pharmacokinetics
  • Acronyms TreoPK
  • Most Recent Events

    • 24 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
    • 05 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top